z-logo
Premium
Analysis of chiral pharmaceuticals using HPLC with CD detection
Author(s) -
Jenkins Amanda L.,
Hedgepeth William A.
Publication year - 2005
Publication title -
chirality
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 77
eISSN - 1520-636X
pISSN - 0899-0042
DOI - 10.1002/chir.20104
Subject(s) - chemistry , naproxen , chirality (physics) , circular dichroism , high performance liquid chromatography , optical rotation , chromatography , detector , naproxen sodium , stereochemistry , organic chemistry , chiral symmetry , optics , medicine , physics , alternative medicine , pathology , quantum mechanics , nambu–jona lasinio model , quark
Abstract Recent American Food and Drug Administration guidelines have effectively determined that mixtures of chiral compounds can no longer be brought to the pharmaceuticals marketplace. These guidelines require a means for chiral detection and compound separation. This article describes separation and detection of chiral pharmaceuticals using HPLC with circular dichroism detection. Two over‐the‐counter (OTC) medications, Prilosec and naproxen sodium, along with the prescription drugs Naproxen, Nexium, and Coumadin were analyzed using HPLC with CD, UV, and optical rotation (OR) detection. In all cases the CD and UV detectors displayed a much greater sensitivity than the OR detector. Although in many cases the UV detector did have a slightly better sensitivity than the CD detector, the CD detector had the advantage of only responding to the chiral compounds, eliminating the possibility of interference with the peaks of interest. Chirality 17:S24–S29, 2005. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here